Advertisement

Role of Calcium Channels in Drug Dependence

  • Fernando Rodríguez de Fonseca
  • Miguel Angel Gorriti
  • Miguel Navarro

Abstract

Drug addiction is a medical illness that has devastating health, social, political and economic consequences. Indeed, it is one of the most important health problems facing the world today. Addiction has this devastating impact despite extensive political effort and social/behavioral research aimed at reducing addiction. Social and psychological approaches to the treatment of addiction — while beneficial to many — have been only partially successful in alleviating the worldwide burden of substance abuse (Koob and Le Moal, 1997; Nestler and Aghajanian, 1997; O’Brien, 1997). Based on recent scientific advances, attitudes toward addiction and approaches to the treatment and prevention of addiction are rapidly changing. It is now clear that addiction should be conceptualized as a brain disease that occurs in susceptible individuals as a consequence of cellular and molecular changes in nervous system function (Koob et al, 1998). It is well established that certain brain circuits, like those involving mesencephalic dopaminergic neurons, are particularly important for mediating the behavioral and psychological actions of drugs abuse (Koob and Le Moal, 1997; Rodriguez de Fonseca and Navarro, 1998). This has led to the development of more sophisticated molecular hypotheses to explain critical features of addiction such as sensitization, tolerance, withdrawal and dependence (Nestler and Aghajanian, 1997; Koob et al., 1998). Molecular pharmacology research as well as genetic studies in inbred strains of rodents and the achievement of genetically modified animals have allowed to find those molecular targets of major abused drugs (Guppy et al., 1995; Koob et al., 1998; Crabbe et al., 1999; Ledent et al., 1999).

Keywords

Calcium Channel NMDA Receptor Drug Dependence Abuse Drug Chronic Ethanol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, 4th edn., American Psychiatric Press, Washington.Google Scholar
  2. Bailey, C.P., Molleman, A. and Little, H.J., 1998, Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol comsumption, Br. J. Pharmacol. 123, 215–222.PubMedCrossRefGoogle Scholar
  3. Bankole, A.J., Roache, J.D., Bordnick, P.S. and Ait-Daoud, N., 1999, Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphet-amine’s positive subjective effects: A preliminary study, Psychopharmacology 144, 295–300.CrossRefGoogle Scholar
  4. Barrios, M. and Baeyens, J.M., 1991, Different effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine, Psychopharmacology 104, 397–403.PubMedCrossRefGoogle Scholar
  5. Bernstein, M.A. and Welch, S.R, 1995, Alterations in L-type calcium channels in the brain and spinal chord of acutely treated and morphine-tolerant mice, Brain Res. 696, 83–88.PubMedCrossRefGoogle Scholar
  6. Bongianni, F., Carla, V., Moroni, F. and Pellegrini-Gianpietro, D.E., 1988, Calcium channels inhibitors suppress the morphine-withdrawal syndrome in rats, Br J. Pharmacol 88, 561–567.CrossRefGoogle Scholar
  7. Calcagnetti, D.J. and Schechter, M.D., 1992, Attenuation of drinking sweetened water following calcium channel blockade, Brain Res. Bull. 28, 967–973.PubMedCrossRefGoogle Scholar
  8. Caro, G., Barrios, M. and Baeyens, J.M., 1988, Dose-dependent and stereoselective antagonism by diltiazem of naloxone-precipitated morphine abstinence after acute morphine-dependence in vivo and in vitro, Life Sci. 43, 1523–1527.PubMedCrossRefGoogle Scholar
  9. Crabbe, J.C., Phillips, T.J., Buck, K.J., Cunningham, C.L. and Belknap, J.K., 1999, Identifying genes for alcohol and drug sensitivity: Recent progress and future directions, Trends Neurosci. 22, 173–179.PubMedCrossRefGoogle Scholar
  10. Dolin, S.J. and Little, H.J., 1989, Are changes in neuronal calcium channels involved in ethanol tolerance?, J. Pharmacol. Exp. Ther. 250, 985–991.PubMedGoogle Scholar
  11. Dolin, S., Little, H., Hudspith, M., Pagonis, C. and Littleton, J., 1987, Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence, Neuropharmacology 26, 275–279.PubMedCrossRefGoogle Scholar
  12. Fan, G.H., Wang, L.Z., Qiu, H.C., Ma, L. and Pei, G., 1999, Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence, Mol. Pharmacol. 56, 39–45.PubMedGoogle Scholar
  13. Gerstin, E.H., McMahon, T., Dadgar, J. and Messing, R.O., 1998, Protein kinase C mediates ethanol-induced up-regulation of L-type calcium channels, J. Biol. Chem. 273, 16409–16414.PubMedCrossRefGoogle Scholar
  14. Goto, M., Lemasters, J J. and Thurman, R.G., 1993, Activation of voltage-dependent calcium channels in kupfer cells by chronic treatment with alcohol in the rat, J. Pharmacol. Exp. Ther. 267, 1264–1268.PubMedGoogle Scholar
  15. Guppy, L.J., Crabbe, J.C., Littleton, J.M., 1995, Time course and genetic variation in the regulation of calcium channel antagonist binding sites in rodent tissues during the induction of ethanol physical dependence and withdrawal, Alcohol Alcohol 30, 607–615.PubMedGoogle Scholar
  16. Herman B.H., Vocci, F. and Bridge, P., 1995, The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction, Neuropsychopharmacology 13, 269–293.PubMedCrossRefGoogle Scholar
  17. Johnson, B.A., Roache, J.D., Bordnick P.S. and Ait-Daoud, N., 1999, Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-amphetamine’s positive subjective effects: A preliminary study, Psychopharmacology 144, 295–300.PubMedCrossRefGoogle Scholar
  18. Kalivas, P.W., Striplin, C.D., Steketee, J.D., Klitenick, M.A. and Duffy, P., 1992, Cellular mechanisms of behavioral sensitization, Anw. N.Y.Acad. Sci. 654, 128–134.CrossRefGoogle Scholar
  19. Kishioka, S., Inoue, N., Nishida, S., Fukunaga, Y. and Yamamoto, H., 1996, Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats, Eur. J. Pharmacol. 361, 7–14.CrossRefGoogle Scholar
  20. Koob, G.F. and Le Moal, M., 1997, Drug abuse: Hedonic homeostatic dysregulation, Science 278, 52–57.PubMedCrossRefGoogle Scholar
  21. Koob, G.F., Sanna, P.P. and Bloom, F.E., 1998, Neuroscience of addiction, Neuron 21, 467–476.PubMedCrossRefGoogle Scholar
  22. Krystal, J.H., Compere, S., Nestler, E.J. and Rasmussen, K., 1996, Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats, Physiol. Behav. 59, 863–866.PubMedCrossRefGoogle Scholar
  23. Kuzmin, A., Semenova, S., Zvartau, E. and De Very, J., 1999, Effects of calcium channel blockade on intravenous self-administration of ethanol in rats, Eur. Neuropsychopharmacol 9, 197–203.PubMedCrossRefGoogle Scholar
  24. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W. and Parmentier, M., 1999, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice, Science 283, 401–404.PubMedCrossRefGoogle Scholar
  25. Littleton, J., Little, H. and Laverty, R., 1992, Role of neuronal calcium channels in ethanol dependence: From cells cultures to the intact animal, Ann. N.Y.Acad. Sci. 654, 324–334.PubMedCrossRefGoogle Scholar
  26. Lynch, M.A. and Littleton, J.M., 1983, Possible association of alcohol tolerance with increased synaptic Ca2+ sensitivity, Nature 303, 175–177.PubMedCrossRefGoogle Scholar
  27. Martellota, M.C., Kuzmin, A., Zvartan, Z., Cossu, G., Gessa, G.L. and Fratta, W., 1995, Isradipine inhibits nicotine intravenous self-administration in drug naive mice, Pharmacol. Biochem. Behav. 52, 271–274.CrossRefGoogle Scholar
  28. Miyakawa, T., Yagi, T., Kitazawa, H., Yasuda, M., Kawai, N., Tsuboi, K. and Niki, H., 1997, Fyn-kinase as a determinant of ethanol sensitivity: Relation to NMDA-receptor function, Science 278, 698–701.PubMedCrossRefGoogle Scholar
  29. Navarro, M., Chowen, J.A., Carrera, M.R.A., Del Arco, L, Villanúa, M.A., Martin, Y, Roberts, A., Koob, G.F. and Rodriguez de Fonseca, F.A., 1998, CB-1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. NeuroReport 9, 3397–3402.PubMedCrossRefGoogle Scholar
  30. Nestler, E.J. and Aghajanian, G.K., 1997, Molecular and cellular basis of addiction, Science 278, 58–62.PubMedCrossRefGoogle Scholar
  31. O’Brien, C.P., 1997, A range of research-based pharmacotherapies for addiction, Science 278, 66–70.PubMedCrossRefGoogle Scholar
  32. Pabello, N.G., Hubbell, C.L., Cavallaro, CA., Barringer, T.M., Mendez, J.J. and Reid, L.D., 1998, Responding for rewarding brain stimulation: Cocaine and isradipine plus naltrexone, Pharmacol. Biochem. Behav. 61, 181–192.PubMedCrossRefGoogle Scholar
  33. Pérez-Vázquez, J.L., Valiante, T.A. and Carlen, P.L., 1994, Changes in calcium currents during ethanol withdrawal in a genetic mouse model, Brain Res. 649, 305–309.CrossRefGoogle Scholar
  34. Pich, E.M., Lorang, M., Yeganeh, M., Rodríguez de Fonseca, F., Raber, J., Koob, G.F. and Weiss, F., 1995, Increase of extracellular corticotropin-releasing factor-like inmunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by mycrodialysis, J. Neurosci. 15, 5439–5447.Google Scholar
  35. Pierce, R.C., Quick, E.A., Reeder, D.C., Morgan, Z.R. and Kalivas, P.W., 1998, Calciummediated second messengers modulate the expression of behavioural sensitization to cocaine, J. Pharmacol. Exp. Ther. 286, 1171–1176.PubMedGoogle Scholar
  36. Pulvirenti, L., Maldonado, R. and Koob, G.F., 1992, NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat, Brain Res. 594, 327–330.PubMedCrossRefGoogle Scholar
  37. Pulvirenti, L., Berrier, R., Kriefeldt, M. and Koob, G.F., 1994, Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat, Brain Res. 664,231–236.PubMedCrossRefGoogle Scholar
  38. Ripley, T.L. and Little, H.J., 1995, Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-Aspartate receptor antagonist, J. Pharmacol. Exp. Ther. 272, 112–118.PubMedGoogle Scholar
  39. Rodríguez de Fonseca, F. and Navarro, M., 1998, Role of the limbic system in dependence on drugs, Ann. Med. 30, 397–405.PubMedCrossRefGoogle Scholar
  40. Rodríguez de Fonseca, F., Carrera, M.R., Navarro, M., Koob, G.F. and Weiss, F, 1997, Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal, Science 276, 2050–2054.PubMedCrossRefGoogle Scholar
  41. Rodríguez de Fonseca, R, Roberts, A.J., Bilbao, A.J., Koob, G.F. and Navarro, M., 1999, Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers, Acta Pharmacol. Sinica 20, 1109–1114.Google Scholar
  42. Rosseti, Z.L., Isola, D., De Very, J. and Fadda, F, 1999, Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal, Neuropsychopharmacology 38, 1361–1369.Google Scholar
  43. Schnur, P., Espinoza, M., Flores, R., Ortiz, S., Vallejos, S. and Wainwright, M., 1992, Blocking naloxone-precipitated withdrawal in rats and hamsters, Pharmacol. Biochem. Behav. 43, 1093–1098.PubMedCrossRefGoogle Scholar
  44. Spanagel, R. and Zieglgänsberger, W., 1997, Anti-craving compounds for ethanol: New pharmacological tools to study addictive process, Trends Pharmacol. Sci. 18, 54–59.PubMedCrossRefGoogle Scholar
  45. Spanagel, R., Sillaber, I., Zieglgänsberger, W., Corrigall, W.A., Stewart, J. and Shaham, Y., 1998, Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress, Psychopharmacology 139, 391–401.PubMedCrossRefGoogle Scholar
  46. Stokes, J.A. and Harris, R.A., 1982, Alcohols and synaptosomal calcium transport, Mol. Pharmacol. 22, 99–104.PubMedGoogle Scholar
  47. Suzuki, T., Mizoguchi, H., Noguchi, H., Yoshii, T. and Misawa, M., 1993, Effects of flunarizine and diltiazem on physical dependence on barbital in rats, Pharmacol. Biochem. Behav. 45, 703–712.PubMedCrossRefGoogle Scholar
  48. Tabakoff, B. and Hoffman, P.L., 1996, Alcohol addiction: An enigma among us, Neuron 16, 909–912.PubMedCrossRefGoogle Scholar
  49. Tokuyama, S. and Ho, I., 1996, Inhibitory effects of diltiazem, an L-type Ca 2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioiddependent rats, Brain Res. 722, 212–216.PubMedCrossRefGoogle Scholar
  50. Tokuyama, S., Feng, Y., Wakabayashi, H. and Ho, I.K., 1995, Ca2+ channel bloker diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats, Eur. J. Pharmacol. 279, 92–98.CrossRefGoogle Scholar
  51. Twitchell, W., Brown, S. and Mackie, K., 1997, Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons, J. Neurophysiol. 78, 43–50.PubMedGoogle Scholar
  52. Wang, X., Wang, G., Lemos, J.R. and Treitsman, S.N., 1994, Ethanol directly modulates gating of a dyhidropyridine-sensitive Ca2+ channel in neurohypophysial terminals, J. Neurosci. 14, 5443–5460.Google Scholar
  53. Watson, W.P., Misra, A., Cross, A.J., Green, A.R. and Little, H.J., 1994, The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice, Br. J. Pharmacol. 112, 1017–1024.PubMedCrossRefGoogle Scholar
  54. Whittington, M.A. and Little, H.J., 1991, A calcium channel antagonist stereoselectively decreases ethanol withdrawal hyperexcitability but not that due to biccuculine, in hippocampal slices, Br. J. Pharmacol. 103, 1313–1320.PubMedCrossRefGoogle Scholar
  55. Wirkner, K., Poelchen, W., Koles, L., Muhlberg, K., Scheibler, P., Allgaier, C. and Illes, P., 1999, Ethanol-induced inhibition of NMDA receptor channels, Neurochem. Int. 35, 153–162.PubMedCrossRefGoogle Scholar
  56. Zerning, G., Fabisch, H. and Fabish, H., 1997, Pharmacotherapy of alcohol dependence, Trends Pharmacol. Sci. 18, 229–231.Google Scholar
  57. Zharkovsky, A., Totterman, A.M., Moisio, J. and Ahtee, L., 1993, Concurrent nimodipine attenuates the withdrawal signs and the increase in cerebral dihydropiridine binding sites after chronic morphine treatment in rats, Naunyn Schmiedeberg Arch. Pharmacol. 347, 483–486.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Fernando Rodríguez de Fonseca
    • 1
  • Miguel Angel Gorriti
    • 1
  • Miguel Navarro
    • 1
  1. 1.Instituto Universitario de Drogodependencias (Departamento de Psicobiología, Facultad de Psicología)Universidad ComplutenseMadridSpain

Personalised recommendations